Aplagon
PrivateLast Round
Early Funding
Jun 16, 2026
Total Funding Raised
$15.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aplagon is a clinical-stage biopharmaceutical company that develops first-in-class therapeutics for thromboinflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aplagon Comparables
Compare Aplagon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanofi | 69% | |
| Bioxodes | 65% | |
| Pfizer | 62% |
Aplagon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 16, 2026 | ||||
| Series A | Feb 3, 2025 | ||||
| Grant | Nov 16, 2022 | ||||
| VC Round | May 28, 2021 | ||||
| Seed | Dec 7, 2018 |
Aplagon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Early Funding, Series A |
| Innovestor | Early Funding, Series A, Seed |
| Helsinki University Funds | Seed |
| Invesdor | VC Round |
| Fåhraeus Startup and Growth | Early Funding, Series A |
| Finnvera | Seed |
| Jenny and Antti Wihuri Foundation | Early Funding, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 36% MoM, from 461 to 627.
- Jun 16, 2026
$6M raised with eic-ec-europa and Fåhraeus Startup and Growth leading.
Recent news
Latest coverage and updates
- is_developingJun 30, 2026
Aplagon Oy is developing APAC on Jun 30th '26.
- hiresJun 29, 2026
Aplagon Oy hired Carl Lindgren as Chair of Board of Directors on Jun 29th '26.
Aplagon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aplagon's valuation, stock price, and market status.
Is Aplagon a public or private company?
Aplagon is a private company.
What is the current stock price of Aplagon?
Aplagon is a private company with no public stock price. No recent secondary market data is available.
How much is Aplagon worth (valuation)?
Valuation information for Aplagon is not publicly available.
Can I buy Aplagon stock?
Aplagon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aplagon's last funding round?
Aplagon's most recent funding round was Early Funding on June 16, 2026.
Who are the main investors in Aplagon?
Key investors in Aplagon include European Innovation Council, Fåhraeus Startup and Growth.
Will Aplagon IPO soon?
No public IPO plans have been announced for Aplagon.
How can I track Aplagon secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aplagon's secondary market activity and sign up for updates.